Clinical Trial: Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI) - Renal and Urology News
Links shared publicly online about this topic.
- 988total visits
Clinical Trial: Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI) - Renal and Urology News
A look at the following clinical trial: Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
View full resource at renalandurologynews.com
Tags: Kidney Health, Urinary System, Kidney Failure, Imaging Tests, Magnetic Resonance Imaging, Clinical Trial, Safety
Most Recently Shared on July 29, 2010 at 5:35 am By:
Clinical Trial: Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for... http://bit.ly/bdeJQp
Advertisement
